Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Teva launches generic blood pressure treatment in US


Teva-Pharmaceutical-Industries

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in the US. Diovan treats high blood pressure and is used by heart disease patients.

Diovan, marketed by Novartis Pharmaceuticals, had annual sales of about $1.8 billion in the US, according to IMS data as of October 2014.

Yesterday, Teva announced the launch of two new generic versions of antibiotics in the US.

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Advertisement